Introduction
Although microbial plaque is a primary etiologic agent responsible for periodontitis, host immune response has long been considered as an important diseasemodifying factor. Considering the protective function of immune response, to determine which immune cell(s) or factor(s) are involved in the destruction of periodontium rather than protection is important to predict disease course and plan treatment. People with defects in neutrophil function demonstrated that neutrophil has a pivotal role in the protection from periodontitis (Cianciola et al., 1977; Clark et al., 1977; Anderson et al., 1985) . Chronically inflamed periodontal tissues are infiltrated densely with lymphocytes as well as phagocytic leukocytes. To understand the role of the infiltrated lymphocytes in the pathogenesis of periodontitis, many investigators studied the number and proportion of lymphocyte populations and established a concept that the change from a stable to a progressive lesion was associated with the increased infiltration of B cells and plasma cells (Mackler et al., 1977; Seymour et al., 1979; Malberg et al., 1992) . However, the role of B cells in the pathogenesis of periodontitis has been controversial: while some insisted that plasma cell predominance per se causes periodontal bone loss (Seymour, 1991; Kinane, 2000) , some insisted that periodontal destruction does not result from the conversion of a predominantly T cell to a predominantly B cell lesion, but rather from episodes of acute inflammation (Page, 1986) .
To clarify this issue, we studied the effect of each activated lymphocyte subset on osteoclast differentiation and activation in vitro and reported previously that osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8 + T cells (Choi et al., 2001) . However, we subsequently observed that B cells could also suppress osteoclastogenesis depending on the activation protocol used. In this study, we demonstrated that B cells activated in the presence of Th1 cytokines suppressed osteoclastogene-
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sis. In addition, we studied cytokine profiles of B cells activated in the absence or presence of Th1 cytokines, and have shown that IFN-γ was a key negative regulator of osteoclastic differentiation and mediated the inhibition of osteoclastogenesis by B cells activated in the presence of IL-2.
M aterials and M ethods M ice and reagents
Four to six week-old C57BL/6 female mice (Han-Lim Laboratory Animal Co. Kyung-gi, Korea), were used for all experiments. Recombinant murine (rm) sRANKL, rmIFN-γ, rmIL-2, and rmIL-10 were purchased from Peprotech (London, UK). Other cytokines including recombinant human (rh) TGF-β, rmIL-4, rmIL-13, and rmTNF-α were purchased from R&D systems (Minneapolis, MN). All monoclonal antibodies were purchased from BD PharMingen (San Diego, CA).
Activation of B cells
Mononuclear leukocytes were isolated from splenocytes by Ficoll separation, and then subjected to Tcell depletion using anti-CD3 Ab-conjugated Dynabeads (Dynal, Lake Success, NY). The purified B cells were re-suspended in α-MEM complete medium (10% fetal bovine serum, 2 mM glutamine, penicillin, streptomycin) at 2×10 6 cells/ml and activated for 2 days with 1 mg/ml anti-IgD Ab clone 217-170, 0.2 mg/ml anti-CD 40 Ab clone HM40-3, and 20 IU/ml rmIL-4, in the absence or presence of Th1 cytokines, either 100 IU/ml rhIL-2 (Chiron Therapeutics, Emeryville, CA) or 50 ng/ml rmIFN-γ. We designate the B cells activated by three different protocols BTh2, BIL-2, and BIFN-γ, respectively. Following B cell-specific activation, few granulocytes survived and most monocytes remained attached to the culture plate. The purities of the activated B cells were confirmed by flow cytometry before co-culture and they were between 95-98%.
In vitro osteoclastogenesis and co-culture w ith activated B cells Murine monocyte cell line RAW264.7 was purchased from ATCC (Bethesda, MD). After expansion, cells at passage 4 or 5 were kept as frozen vials and freshly thawed cells were used for all experiments. For tartrate resistant alkaline phosphatase (TRAP) stain and TRAP enzyme activity assay, RAW264.7 cells were plated into 96-well plates at 2,500 cells/0.15 ml/well in α-MEM complete medium with murine soluble RANKL (20 ng/ml). On day 2, the medium with sRANKL was replaced with fresh one and co-cultured with activated B cells (5×10 5 cells/well) for another 3 days. For resorption assay, RAW264.7 cells were plated in 48-well Osteoclast Activity Assay System plates (OAAS; Oscotec, Korea) at 4,500 cells/0.3 ml/well in α-MEM complete medium with murine soluble RANKL (20 ng/ml) for 2 days, and then co-cultured with activated B cells (10 6 cells/well) for another 6 days, replacing them once with new activated B cells on day 5. After co-culture, the supernatants were saved and kept in -70 o C for ELISA assay. For neutralization of IFN-γ, various amounts of anti-INF-γ mAb, clone H22 were added with BIL-2 cells from day 2 to 5.
TRAP activity assay
After wash, the entire adherent cells in each well were lysed with 50 µl RIPA buffer. TRAP activity was measured by the conversion of α-naphthyl phosphate (2.5 mM; Sigma) to α-naphthol in the presence of 25 mM L-tartrate solution (Sigma). Absorbance was measured at 405 nm using a microplate reader.
TRAP stain
After wash, cells were fixed with 3% formaldehyde in acetone for 30 s. Cells were stained for TRAP using a leukocyte acid phosphatase staining kit (No. 387, Sigma) . TRAP + cells with three or more nuclei were regarded as osteoclasts and counted under an inverted-phase contrast microscope.
Resorption assay
After termination of culture, all remaining cells on the OAAS plates were lyzed using 1 M NaOH. The image (×40) of an entire well was captured, and resorbed area was measured using a computer-assisted image analyzer (ImagePro v4.0; Media Cybernetics, Bethesda, MD).
Reverse transcription (RT)-PCR
Total RNA was extracted from B cells that were activated for 2 days with three different protocols. Total RNA (1 µg) was subjected to RT with (dT)16 and 1 µl of Superscript II enzyme (GibcoBRL, NY) in 20 ml reaction mix. After 1 h at 42 o C, 1 µl and serially diluted samples (1/5 and 1/25) were subjected to PCR in cycling conditions: 94 o C, 20 s; 60 o C, 30 s; 72 o C, 1 min for 35 cycles. Actin gene amplified for 25 cycles served a control for RNA input. Primer sequences used are listed in Table 1 .
ELISA
The amounts of IL-2, IL-4, IL-10, and IFN-γ secreted into media during co-culture with activated B cells, were measured using ELISA kits from R&D systems. Cytokines in the media from the culture of osteoclasts alone were also measured.
Statistics
Unless stated otherwise, Student t-test was performed to compare experimental wells with control wells that were cultured with sRANKL alone.
R esults B cells activated in the presence of Th1 cytokines suppress osteoclastogenesis
Previously, we reported that activated B cells enhance osteoclastogenesis (Choi et al., 2001) . However, we subsequently observed that the activated B cells could have different effects on osteoclastic differentiation depending on the activation protocol: while B cells activated with PW M following T cell depletion enhanced osteoclastogenesis, B cells activated in the presence of T cells followed by T cell depletion suppressed it (data not shown). These observations suggested that some factor(s) from T cells changed the phenotype of the activated B cells, thereby effects on osteoclastogenesis. Since the suppressive effect was further aggravated by addition of IL-2, we hypothesized that Th1 cells as well as Th2 cells might have a role in B cell activation. The exact mechanism of signaling or activation by PWM is not known, therefore, we modified our activation protocol to test our hypothesis. B cells activated with anti-IgD Ab, anti-CD 40 Ab, and IL-4, simulated Th2 cell-dependent B cell activation (BTh2). To simulate B cell activation under the influence of Th1 cells as well as Th2 cells, purified B cells were incubated with anti-IgD Ab, anti-CD 40 Ab, and IL-4 plus either IL-2 (BIL-2) or IFN-γ (BIFN-γ). For in vitro osteoclastogenesis, we adopted a well-established model system using RAW-264.7 cells that comprise a pure population of monocytic lineage and easily differentiate into osteoclasts after 5 to 6 days in culture in the presence of sRANKL (Hsu et al., 1999; Shevde et al., 2000) . On day 2 when we started co-culture with activated B cells, all cells still were mononuclear and less than 20% were TRAP + . Following co-culture, the influence of activated B cells on the osteoclast differentiation was evaluated by the formation of TRAP + multinuclear cell (MNC), TRAP activity, and resorption of coated minerals. All three assays showed that BTh2 increased osteoclastogenesis but either BIL-2 or BIFN-γ suppressed it substantially (Figure 1 ).
The phenotypes of activated B cells
These results suggested that the presence of Th1 cytokines during activation altered the phenotypes of activated B cells. B cells secrete various cytokines that affect osteoclastogenesis positively or negatively. We studied the expression profile of pro-and antiinflammatory, Th1, and Th2 cytokines as well as RANKL, osteoprotegerin (OPG) and RANK using semi-quantitative RT-PCR (Figure 2A) . First, there was no difference in the expression of the key regulators of osteoclastogenesis, RANKL and OPG: all expressed high levels of RANKL but no OPG. The expression of RANK was not observed, either. All three types of B cells expressed similar levels of a pro-inflammatory cytokine, TNF-α, but an anti-inflammatory cytokine, TGF-β in different levels, being BIFN-γ BIL-2 BTh2. We had expected that the presence of Th1 cytokines during activation might skew the cytokine profile toward Th1, but such a pattern was not observed clearly. In general, all three types of B cells expressed both Th1 and Th2 cytokines. However, increased expression of IFN-γ by BIL-2 and decreased expression of Th2 cytokines including IL-4, IL-5, and IL-10 by BIFN-γ were noted. Since IL-4, IL-2, and IFN-γ were added in saturating levels during activation, B cells might have turned off their own synthesis, producing artificially low mRNA results by RT-PCR. Therefore, we also measured the amounts of the cytokines secreted into supernatants upon co-culture by ELISA. As shown in Figure 2B , the results by ELISA quite well reflected the results by RT-PCR: BIL-2 expressed a high level of IFN-γ and BIFN-γ expressed the lowest levels of IL-4 and IL-10.
IFN -γ is a key negative regulator of osteoclast differentiation and m ediates the suppressive effect of B IL-2 cells
Interestingly, TRAP -MNCs, rather than TRAP + MNCs, were often observed upon co-culture with BIL-2 cells ( Figure 3A) . These TRAP -MNCs did not have actin rings at the periphery (data not shown), and they phagocytosed beads ( Figure 3A) , a characteristic of giant cells. IFN-γ is known to induce the formation of giant cells and indeed as small as 1 ng/ml of IFN-γ could convert the developing osteoclasts into giant cells ( Figure 3B ).
These results indicated that IFN-γ must be a major factor mediating the suppressive effect by BIL-2, and it was clearly confirmed by the use of anti-IFN-γ neutralizing mAb (Figure 4 ). In the control experiment without BIL-2, the anti-IFN-γ mAb did not have much effect on either TRAP activity or formation of TRAP + MNC. In contrast, upon co-culture with BIL-2, the anti-IFN-γ mAb reversed the suppressive effect of BIL-2 completely (TRAP + MNC) and increased the level of TRAP activity even higher than that of control. It suggested that IFN-γ is a key suppressor secreted from BIL-2 and with the function of IFN-γ blocked, BIL-2 may also enhance osteoclastogenesis.
BIL-2 express cytokines that are known to antagonize IFN-γ mediated activation of macrophage: IL-4, IL-13, IL-10, and TGF-β (Gazzinelli et al., 1992; Hausmann et al., 1994; Paludan et al., 1997; Paludan et al., 1998) . We tested if these cytokines can antagonize the effect of IFN-γ on osteoclasts, too. In addition, we tested TNF-α that induces high expression of tumor necrosis factor receptor-associated factor 6 (TRAF6) since IFN-γ inhibits osteoclastogenesis by degrading TRAF6 (Takayanagi et al., 2000; Zhang et al., 2001) . 2 ng/ml IFN-γ decreased the TRAP activity and TRAP + MNC about 50%, a similar level obtained by co-culture with BIL-2. Therefore, instead of co-culture with BIL-2, 2 ng/ml IFN-γ plus various cytokines were added from day 2 to day 5 during osteoclastogenesis using RAW264.7 cells. Among tested cytokines (TNF-α, IL-4, IL-13, IL-10, and TGF-β), only TNF-α showed a slight antagonistic effect but it never antagonized the effect of IFN-γ completely even at high concentration ( Figure 5 ). 
D iscussion
In this study, we have demonstrated that cytokine environment during B cell activation can change the phenotype of the activated cells. Recently, it was shown that B cells co-cultured with Th1 cells or Th2 cells differentiated into two populations of effector B cells that secrete Th1 cytokines and Th2 cytokines, respectively (Harris et al., 2000) . Although such a clear polarized pattern was not observed, BIL-2 expressed an increased level of IFN-γ and BIFN-γ expressed decreased levels of Th2 cytokines including IL-4, IL-5, and IL-10 compared with BTh2 (Figure 2A and 2B). Several cytokines and surface molecules, rather than a single cytokine, may be required to induce completely polarized effector cells. In addition, activated B cells may have heterogeneous phenotypes between two completely polarized types depending on their micro-environment during activation. B cells first encounter Ag and undergo initial activation in the T cell zone of peripheral lymphoid organs, where the Th1/Th2 cytokine balance in the vicinity of B cells during activation is known to affect the phenotypes of activated B cells. BTh2 expressed pro-osteolytic factors including RANKL, TNF-α, and TNF-β but low levels of strong suppres (Manabe et al., 2001 ). When we stained B cells with succinimidyl ester of carboxyfluorescein diacetate (CFSE) and co-cultured with RAW264.7 cells, none of the differentiated osteoclasts had fluorescence (data not shown), excluding the possibility that B cell themselves differentiate into osteoclasts as suggested from the shared lineage in these two cells (Sato et al., 2001) . Compared with BTh2, BIL-2 expressed high levels of IFN-γ as well as RANKL, TNF-α, and TNF-β (Figure 2A) . Induction of many giant cells by co-culture with BIL-2 suggested that IFN-γ had an important role in the inhibitory action, which was confirmed by the use of anti-IFN-γ neutralizing Ab (Figure 4 ). BIL-2 also expressed cytokines that are known to antagonize IFN-γ mediated activation of macrophage: IL-4, IL-13, 1L-10, and TGF-β (Gazzinelli et al., 1992; Hausmann et al., 1994; Paludan et al., 1997; Paludan et al., 1998) . However, none of these could reverse IFN-γ mediated inhibition of osteoclastogenesis. TNF-α that induces the expression of TRAF6 (Kaji et al., 2001; Zhang et al., 2001) showed a slight antagonistic effect, but never reversed the inhibitory effect completely ( Figure 5 ).
These results suggested that: 1) IFN-γ uses different signal pathways in macrophages and osteoclasts; 2) IFN-γ is a key negative regulator of osteoclastogenesis even in the presence of RANKL, TNF-α and TNF-β.
How BIFN-γ inhibited osteoclastogenesis is not clear at present. TGF-β might have a role as shown by Weitzmann et al., although the role of TGF-β in osteoclastogenesis is controversial (Weitzmann et al., 2000) . Otherwise, cytokines that we did not analyze or unknown factors produced by BIFN-γ may have played a role.
In summary, we have demonstrated that Th2-dependent B cells and B cells activated in the presence of Th1 cytokines, IL-2 or IFN-γ, have opposite effects on osteoclastogenesis in vitro, acting positively and negatively, respectively. In addition, we have shown that IFN-γ is a key negative regulator of osteoclastogenesis that mediated the inhibitory effect of BIL-2 in the presence of two major osteoclast inducing factors, RANKL and TNF-α. Our findings suggested that activated B cells infiltrated into inflammation sites should not be regarded as cells of a uniform phenotype and Th1 cytokines might protect against bone destruction in an inflammatory bone disease such as periodontitis, acting directly on osteoclasts or indirectly through B cells. 
